Alpha 1-3 N-galactosyltransferase with altered donor specificities

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8425901
APP PUB NO 20110217235A1
SERIAL NO

12674638

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention generally features compositions and methods based on the structure-based design of alpha 1-3 N-Acetylgalactosaminyltransferase (alpha 3 GaINAc-T) enzymes from alpha 1-3 galactosyltransferase (a3Gal-T) that can transfer 2′-modified galactose from the corresponding UDP-derivatives due to substitutions that broaden the alpha 3Gal-T donor specificity and make the enzyme a3 GaINAc-T.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HEALTH AND HUMAN SERVICES GOVERNMENT OF THE UNITED OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF6011 EXECUTIVE BOULEVARD SUITE 325 ROCKVILLE MD 20852

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boeggeman, Elizabeth Bethesda, US 6 8
Pasek, Marta Frederick, US 2 0
Qasba, Pradman K Bethesda, US 6 8
Ramakrishnan, Boopathy Frederick, US 47 101

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation